BioSpace News Archive

Healthier Together CAPP+ Pilot Project Provides Health Education and Home Repairs to Reduce Asthma Triggers, Create Healthier Homes for Children

Qualigen continues to strengthen its cancer drug technology portfolio

Funding will support Progenra’s development of small molecules for treatment of Parkinson’s Disease

Insulet Corporation today announced that management will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 8, 2019, at 11:30 a.m. (Pacific Time).

DexCom, Inc. today announced that management will present an update on Dexcom at the following upcoming investor conference

A new report commissioned by the National Organization for Rare Disorders (NORD) and published today by the IQVIA Institute, demonstrates that the seven-year market exclusivity granted to drugs designated under the Orphan Drug Act of 1983 for rare diseases is working as intended.

AstraZeneca today announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has now received formal marketing authorisation from the National Medical Products Administration (NMPA) for roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) and new oral treatment for patients with anaemia caused by chronic kidney disease (CKD) that are on dialysis.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it has signed a Definitive Agreement with Endo International plc’s (NASDAQ: ENDP) subsidiary, Endo Ventures Limited, for the further development and commercialization of generic Sabril®

Reston Hospital Center’s Spine Team continues to surpass milestones in surgical advancements. Recently, RHC Spine Surgeons Dr. Colin Haines and Dr. Christopher Good from the Virginia Spine Institute performed the world’s first spinal surgery using a combined method of both robot-guided and endoscopic technology.

Blue Cross Blue Shield of Arizona (BCBSAZ) and Phoenix Children’s Hospital announced the two organizations reached agreement on a new three-year contract. Under this new Contract, Phoenix Children’s Hospital will continue to be an in-network provider for BCBSAZ members and those families insured under plans that utilize the BCBSAZ network.